{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T19:10:04Z","timestamp":1793214604937,"version":"4.5.0"},"reference-count":10,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Ophthalmol"],"published-print":{"date-parts":[[2020]]},"DOI":"10.4103\/ijo.ijo_2249_19","type":"journal-article","created":{"date-parts":[[2020,8,20]],"date-time":"2020-08-20T13:06:33Z","timestamp":1597928793000},"page":"1981","source":"Crossref","is-referenced-by-count":14,"title":["Rituximab therapy combined with methotrexate for severe necrotizing scleritis in a case of granulomatosis with polyangiitis"],"prefix":"10.4103","volume":"68","author":[{"given":"SomasheilaI","family":"Murthy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahil","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhupesh","family":"Bagga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajkiran","family":"Dudam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0301-4738.292552-1","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/S0140-6736(06)68583-8","article-title":"Wegener's granulomatosis","author":"Woywodt","year":"2006","journal-title":"Lancet"},{"key":"key-10.4103\/0301-4738.292552-2","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.semarthrit.2005.12.003","article-title":"Wegener's granulomatosis: Ophthalmic manifestations and management","author":"Pakrou","year":"2006","journal-title":"Semin Arthritis Rheum"},{"key":"key-10.4103\/0301-4738.292552-3","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s12177-009-9044-4","article-title":"Ocular disease in patients with ANCA-positive vasculitis","author":"Watkins","year":"2010","journal-title":"J OculBiol Dis Infor"},{"key":"key-10.4103\/0301-4738.292552-4","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.autrev.2011.07.001","article-title":"Anti-CD 20 monoclonal antibody (rituximab) treatment for inflammatory ocular diseases","author":"Miserocchi","year":"2011","journal-title":"Autoimmun Rev"},{"key":"key-10.4103\/0301-4738.292552-5","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s12016-007-8026-1","article-title":"Analysis of Wegener's granulomatosis responses to rituximab: Current evidence and therapeutic prospects","author":"Aouba","year":"2008","journal-title":"Clin Rev Allergy Immunol"},{"key":"key-10.4103\/0301-4738.292552-6","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa0909905","article-title":"RAVE ITN Research Group.Rituximab versus cyclophosphamide for ANCA associated vasculitis","author":"Stone","year":"2010","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0301-4738.292552-7","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.autrev.2019.03.001","article-title":"Ocular involvement in granulomatosis with polyangiitis: A single-center cohort study on 63 patients","author":"Perez-Jacoiste","year":"2019","journal-title":"Autoimmun Rev"},{"key":"key-10.4103\/0301-4738.292552-8","doi-asserted-by":"crossref","first-page":"126","DOI":"10.4103\/0973-3698.187419","article-title":"Cehcklist prior to biologics: Indian perspective","author":"Dudam","year":"2016","journal-title":"Indian J Rheumatol","ISSN":"https:\/\/id.crossref.org\/issn\/0973-3698","issn-type":"print"},{"key":"key-10.4103\/0301-4738.292552-9","doi-asserted-by":"crossref","first-page":"591","DOI":"10.4103\/ijo.IJO_811_17","article-title":"Progressive outer retinal necrosis after rituximab and cyclophosphamide therapy","author":"Dogra","year":"2018","journal-title":"Indian J Ophthalmol","ISSN":"https:\/\/id.crossref.org\/issn\/0301-4738","issn-type":"print"},{"key":"key-10.4103\/0301-4738.292552-10","doi-asserted-by":"crossref","unstructured":"Calabrese LH, Molloy ES. Therapy: Rituximab and PML risk-informed decisions needed! Nat Rev Rheumatol 2009;5:528-9.","DOI":"10.1038\/nrrheum.2009.193"}],"container-title":["Indian Journal of Ophthalmology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T18:51:59Z","timestamp":1786733519000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijo.IJO_2249_19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":10,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020]]}},"alternative-id":["292552"],"URL":"https:\/\/doi.org\/10.4103\/ijo.ijo_2249_19","relation":{},"ISSN":["0301-4738"],"issn-type":[{"value":"0301-4738","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]}}}